Delivery Order SPE2DB20D2104-SPE2DB25FMTUU
Award Date 6/23/25
Potential Completion Date 6/24/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JATENZO 237 MG CAPSULE 120S. The contract has a ceiling value of $1,131.87 and a period of performance through June 6, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a $1,182.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, with a period of performance through January 16, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,152.31, is for the supply of JATENZO 237 MG CAPSULE 120S, a medical product, to support federal government healthcare programs. The contract has an ultimate completion date of January 21, 2025 and does not have a set-aside designation, indicating open competition....
- This is a $1,137.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply JATENZO 237 MG CAPSULE 120S. The contract has a ceiling value of $1,137.35 and a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the supply of JATENZO 158 MG CAPSULE 120S, a prescription medication. The delivery order has a ceiling value of $2,359.66 and a period of performance through April 10, 2024. AmerisourceBergen Drug Corp also holds a separate indefinite delivery contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, with a firm fixed price ceiling value of $1,392.11 and a performance period ending on May 28, 2025. The contract is not set aside and was awarded on May 27, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has a ceiling value of $5,550.82 and a completion date of September 30, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor responsible for delivering the required medical commodity to support...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of JATENZO 158 MG CAPSULE 120S, a pharmaceutical product, and has a ceiling value of $3,840. The contract does not have a set-aside designation and will run through April 1, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award and holds a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JATENZO 237 MG CAPSULE 120S. The contract has a firm fixed price of $2,526.14 and a completion date of July 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,674.44, is for the supply of JATENZO 198 MG CAPSULE 120S, a prescription drug product. The contract has a final completion date of September 11, 2024 and is structured as a firm fixed-price arrangement. This contract award is not associated with any set-aside program. AmerisourceBergen, through its Corporate Office...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMTUUDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 158 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $1,131.88 and a period of performance through June 24, 2025. The contract is not set-aside and was awarded on June 23, 2025. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors listed. The DLA is the funding agency for this contract, which is part of the agency's broader medical supply procurement program supporting the Department of Defense and other government healthcare needs.
Generated 9/22/25, 9:48 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/23/25 |